These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 168121)

  • 21. [Treatment of ulcerative colitis during the active phase. Clinical study].
    Morettini A; Allamani A; Botti P; Innocenti S; Morandi S
    Minerva Dietol Gastroenterol; 1983; 29(2):117-22. PubMed ID: 6136010
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis.
    Mantzaris GJ; Hatzis A; Kontogiannis P; Triadaphyllou G
    Am J Gastroenterol; 1994 Jan; 89(1):43-6. PubMed ID: 8273796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a synthetic 25 amino acid corticotrophin in normal man.
    Rose LI; Williams GH; Jagger PI; Lauler DP
    Clin Pharmacol Ther; 1968; 9(6):740-4. PubMed ID: 4301829
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of premedication with intravenous corticosteroids and antihistaminics in preventing infusion reactions to infliximab].
    Bermejo F; López San Román A; Algaba A; van Domselaar M; Carneros JA; Rivero M; Piqueras B; Valer MP
    Gastroenterol Hepatol; 2008 Dec; 31(10):629-32. PubMed ID: 19174078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The drug therapy of ulcerative colitis and of Crohn's disease.
    Tumen HJ
    Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn's colitis.
    Levine DS; Fischer SH; Christie DL; Haggitt RC; Ochs HD
    Am J Gastroenterol; 1992 Jan; 87(1):91-100. PubMed ID: 1728132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of corticosteroids.
    Meyers S
    Mt Sinai J Med; 1983; 50(2):141-3. PubMed ID: 6304503
    [No Abstract]   [Full Text] [Related]  

  • 29. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW; Gales BJ
    Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticosteroid production in abetalipoproteinemia: evidence for an impaired response ACTH.
    Illingworth DR; Kenny TA; Connor WE; Orwoll ES
    J Lab Clin Med; 1982 Jul; 100(1):115-26. PubMed ID: 6283000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemistry, pharmacology, pharmacokinetics, and clinical applications of mesalamine for the treatment of inflammatory bowel disease.
    Small RE; Schraa CC
    Pharmacotherapy; 1994; 14(4):385-98. PubMed ID: 7937276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACTH-induced cortisol production in multiple sclerosis.
    Snyder BD; Lakatua DJ; Doe RP
    Ann Neurol; 1981 Oct; 10(4):388-9. PubMed ID: 6274253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
    Korelitz BI; Present DH; Rubin PH; Fochios SE
    J Clin Gastroenterol; 1984 Feb; 6(1):27-31. PubMed ID: 6142067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic principles for chronic inflammatory bowel disease].
    Binder V; Munkholm P
    Ugeskr Laeger; 2001 Jan; 163(1):16-21. PubMed ID: 11586666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical application of a new synthetic ACTH, DW-75 (D-serine-1-norleucine-4-valinamide-25-beta-1-25-corticotropin)].
    Matsumoto Y; Isurugi K; Kinoshita K; Takayasu H
    Nihon Naibunpi Gakkai Zasshi; 1970 Aug; 46(5):534-8. PubMed ID: 4318387
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of cyclosporin with corticotropin for refractory ulcerative colitis.
    Okamura S; Aoki H; Ohashi S; Urano F; Shimodaira M; Kanamori S; Ishikawa H; Segawa K
    Hepatogastroenterology; 2003; 50(49):91-4. PubMed ID: 12629999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Budesonide and inflammatory bowel disease].
    Gomollón F; Hinojosa J; Nos P
    Gastroenterol Hepatol; 1999 Dec; 22(10):525-32. PubMed ID: 10650668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.